Inhibition of eNOS Partially Blunts the Beneficial Effects of Nebivolol on Angiotensin II-Induced Signaling in H9c2 Cardiomyoblasts

We have recently illustrated that nebivolol can inhibit angiotensin II (Ang II)-mediated signaling in cardiomyoblasts; however, to date, the detailed mechanism for the beneficial effects of nebivolol has not been studied. Here, we investigated whether the inhibition of NO bioavailability by blocking...

Descripción completa

Detalles Bibliográficos
Autores principales: Gul, Rukhsana, Alsalman, Nouf, Alfadda, Assim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164031/
https://www.ncbi.nlm.nih.gov/pubmed/35678673
http://dx.doi.org/10.3390/cimb44050144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164031/
https://www.ncbi.nlm.nih.gov/pubmed/35678673
http://dx.doi.org/10.3390/cimb44050144

Ejemplares similares